Research identifies U.S. areas for targeted colorectal cancer screening in Hispanic/Latino communities

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

A recent report showed that UPMC Hillman Cancer Center generated $3.98 billion in total economic impact in Pennsylvania through its clinical, research, and educational missions in 2023.

January 17, 2025

Vol.51 No.02

Drugs & Targets

FDA approves sotorasib + panitumumab for KRAS G12C-mutated colorectal cancer

FDA approved sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated metastatic colorectal cancer, as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

January 17, 2025

Vol.51 No.02

Clinical Trials & Tribulations

New colorectal cancer screening strategies must advance the standard of care

Colorectal cancer is the second leading cause of cancer-related death in the United States. Accurate and early detection of CRC and precancerous lesions is critical for reducing incidence and preventing deaths from this disease.

Johns Hopkins, Howard University reform collaboration to advance health equity

A collaborative effort to eliminate cancer health disparities among African Americans and other underserved populations in the Washington, DC, area is being reignited at the Johns Hopkins Kimmel Cancer Center and the Howard University Cancer Center.

January 10, 2025

Vol.51 No.01

In Brief

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

The University of Hawai‘i Cancer Center and the John A. Burns School of Medicine are forming Ka ʻUmeke Lama, an initiative to transform cancer care in Hawaiʻi and the Pacific.

January 10, 2025

Vol.51 No.01

In Brief

ASC CAN: Congress missed a critical opportunity to prioritize cancer prevention and access to care

In December, Congress failed to advance a bipartisan year-end health care package that would have made a big difference in the fight against cancer, according to the American Cancer Society Cancer Action Network.

January 10, 2025

Vol.51 No.01

Research identifies U.S. areas for targeted colorectal cancer screening in Hispanic/Latino communities

YOU MAY BE INTERESTED IN

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

FDA approves sotorasib + panitumumab for KRAS G12C-mutated colorectal cancer

New colorectal cancer screening strategies must advance the standard of care

Johns Hopkins, Howard University reform collaboration to advance health equity

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

ASC CAN: Congress missed a critical opportunity to prioritize cancer prevention and access to care

Renew today!

Subscriber content

Never miss an issue!

Login